Novel Technologies for Vaccine Development
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Reverse Genetics Approaches for Rational Design of Inactivated and Live Attenuated Influenza Vaccines
-
Altmetric BadgeChapter 2 Viral-Vectored Vaccines to Control Pathogenic Filoviruses
-
Altmetric BadgeChapter 3 Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention
-
Altmetric BadgeChapter 4 Current Status and Future of Polio Vaccines and Vaccination
-
Altmetric BadgeChapter 5 Current Status of Hantavirus Vaccines Development
-
Altmetric BadgeChapter 6 Experimental DNA-Launched Live-Attenuated Vaccines Against Infections Caused by Flavi- and Alphaviruses
-
Altmetric BadgeChapter 7 Sugar-Based Immune Adjuvants for Use in Recombinant, Viral Vector, DNA and Other Styles of Vaccines
-
Altmetric BadgeChapter 8 Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
-
Altmetric BadgeChapter 9 Radiovirotherapy for the Treatment of Cancer
-
Altmetric BadgeChapter 10 TRICOM Poxviral-Based Vaccines for the Treatment of Cancer
-
Altmetric BadgeChapter 11 The Use of Oncolytic Herpesvirus for the Treatment of Cancer
-
Altmetric BadgeChapter 12 SA-4-1BBL: A Novel Form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines
Attention for Chapter 8:
Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines